Personalized Cannabinoid Therapy Systems with AI, IoT, and Blockchain Integration

The present inventive concept integrates cannabinoid formulations with AI, IoT, and blockchain technologies to create a personalized, secure, and efficient system for optimizing cannabinoid therapy.

The original patent disclosed cannabinoid formulations designed to align with an individual's genotype. However, the formulations were limited by the lack of integration with advanced technologies, resulting in inefficiencies in data management, formulation optimization, and patient monitoring. The present inventive concept addresses these limitations by incorporating AI, IoT, and blockchain technologies to create a more powerful and effective system.

The system comprises a genotype analysis module, a cannabinoid formulation generator, and a blockchain-based secure storage system for storing and managing individualized formulations. The AI-powered formulation generator uses machine learning algorithms to analyze a subject's genotype and medical history, generating a set of potential formulations and selecting an optimal one based on predicted efficacy and safety. The IoT-enabled wearable device monitors cannabinoid effects, transmitting data to a cloud-based server for analysis and personalized recommendations. The blockchain-based platform tracks and verifies the authenticity of cannabinoid formulations, ensuring quality control and certification.

The integration of AI, IoT, and blockchain technologies with cannabinoid formulations is a novel and non-obvious combination that provides a significant improvement over the original patent. The use of AI for formulation optimization, IoT for real-time monitoring, and blockchain for secure data management and authentication represents a new and inventive approach to personalized cannabinoid therapy.

Alternative embodiments of the inventive concept could include the use of different AI algorithms, IoT devices, or blockchain platforms. Variations could include the integration of additional technologies, such as virtual or augmented reality, to enhance the patient experience and improve treatment outcomes.

The inventive concept has significant commercial potential in the cannabis and pharmaceutical industries, with potential applications in personalized medicine, medical research, and patient care. The market for personalized cannabinoid therapy systems is expected to grow rapidly, driven by increasing demand for targeted and effective treatments.